ARTICLE | Company News
Universite Laval, AmorChem deal
September 1, 2014 7:00 AM UTC
The university granted VC fund AmorChem an exclusive, worldwide license to a gene therapy program to treat Friedreich’s Ataxia. The university plans to optimize the gene therapy and test it in a mouse...